UNICA IRIS Institutional Research Information System

BIANCO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 88.616
NA - Nord America 2.591
AS - Asia 995
Continente sconosciuto - Info sul continente non disponibili 132
SA - Sud America 126
AF - Africa 48
OC - Oceania 1
Totale 92.509
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 87.970
US - Stati Uniti d'America 2.539
SG - Singapore 367
CN - Cina 343
SE - Svezia 172
UA - Ucraina 140
DE - Germania 110
BR - Brasile 91
VN - Vietnam 76
FI - Finlandia 66
IN - India 52
GB - Regno Unito 51
HK - Hong Kong 37
FR - Francia 36
BD - Bangladesh 30
CA - Canada 25
MA - Marocco 17
PK - Pakistan 17
AR - Argentina 14
JP - Giappone 14
PL - Polonia 12
KR - Corea 10
MX - Messico 10
RU - Federazione Russa 9
LT - Lituania 8
BE - Belgio 7
NL - Olanda 7
ID - Indonesia 6
SA - Arabia Saudita 6
TN - Tunisia 6
VE - Venezuela 6
ZA - Sudafrica 6
EG - Egitto 5
ES - Italia 5
IL - Israele 5
IQ - Iraq 5
NP - Nepal 5
TR - Turchia 5
AT - Austria 4
CO - Colombia 4
NG - Nigeria 4
PT - Portogallo 4
EU - Europa 3
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
SV - El Salvador 3
AL - Albania 2
BB - Barbados 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
IE - Irlanda 2
KW - Kuwait 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SL - Sierra Leone 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 92.381
Salva come PNG Salva come JPEG
Città #
Cagliari 86.915
Uta 958
Ashburn 337
Singapore 224
Fairfield 198
Woodbridge 149
San Jose 135
Chandler 128
Houston 110
Nyköping 107
Seattle 98
Dallas 90
Boardman 87
Wilmington 85
Ann Arbor 78
Beijing 72
Dearborn 61
Cambridge 59
Los Angeles 57
Jacksonville 55
Helsinki 46
Council Bluffs 42
Shanghai 39
New York 37
Hong Kong 36
Santa Clara 31
Boston 27
Nanjing 25
Ho Chi Minh City 23
Lauterbourg 21
Dong Ket 18
The Dalles 18
Redwood City 17
Casablanca 16
Munich 15
Chennai 13
Hanoi 12
Shenyang 12
Hefei 11
London 11
San Diego 11
São Paulo 11
Phoenix 10
Warsaw 10
Atlanta 9
Buffalo 9
Mumbai 9
San Francisco 9
Seoul 9
Chicago 8
Frankfurt am Main 8
Nanchang 8
Orem 8
Tianjin 8
Brooklyn 7
Brussels 7
Hebei 7
Jiaxing 7
Mountain View 7
Multan 7
Rome 7
Tokyo 7
Changsha 6
Herndon 6
Jinan 6
Verona 6
Amsterdam 5
Jakarta 5
Mexico City 5
Montreal 5
Zhengzhou 5
Berkeley 4
Columbus 4
Denver 4
Dhaka 4
Ibadan 4
Johannesburg 4
Lahore 4
Manchester 4
North Bergen 4
Ottawa 4
Pune 4
Redmond 4
Rio de Janeiro 4
Sassari 4
Springfield 4
Toronto 4
Walnut 4
Amman 3
Auburn Hills 3
Betim 3
Caracas 3
Greater Noida 3
Guangzhou 3
Guarulhos 3
Guatemala City 3
Jeddah 3
La Jolla 3
Newark 3
Ningbo 3
Totale 90.809
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.760
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.080
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.730
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.461
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.444
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.361
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.211
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.970
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.802
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.778
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.557
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.537
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.397
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.236
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 3.066
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.946
MD protocol validation for the study of MAOB-inhibitor complexes 2.800
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.771
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.710
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.636
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.567
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.484
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 2.124
Structure-based approaches applied to the study of pharmaceutical relevant targets 1.081
Totale 92.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.135
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.350 0 0 0 0 325 189 184 175 334 399 364 380
2022/20235.424 422 849 778 571 353 550 226 340 307 281 381 366
2023/20244.513 314 162 376 270 407 827 502 386 290 236 341 402
2024/202518.698 8.046 5.226 3.011 806 411 515 386 37 82 46 47 85
2025/20261.982 141 94 202 136 165 139 258 164 128 319 110 126
2026/2027537 34 60 185 245 13 0 0 0 0 0 0 0
Totale 92.509